The provider injects 0.25 mL of a four–strain influenza virus vaccine into a patient’s muscle to provide immunity to four forms of influenza, a severe and infectious respiratory disease; the vaccine is free of preservatives and derived from cell cultures of a killed virus and contains a substance that increases the patient’s immune response.
For clinical responsibility, terminology, tips and additional info
start codify free trial.